605166.SH
聚合顺
SSE · Basic Materials · Chemicals - Specialty · CN
CNY 8.17
−2.16%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 5.1B | 5.5B | 7.2B | 6.0B | 6.0B |
| Cost of Revenue | 4.8B | 5.2B | 6.6B | 5.6B | 5.7B |
| Gross Profit | 338.8M | 368.3M | 577.5M | 403.4M | 377.6M |
| Operating Expenses | |||||
| R&D Expense | 157.7M | 167.8M | 179.1M | 158.4M | 111.6M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 46.8M | 44.4M | 40.9M | 37.1M | 31.0M |
| Selling & Marketing Expense | 15.9M | 14.3M | 10.2M | 11.5M | 10.9M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 202.0M | 201.1M | 201.2M | 172.2M | 98.6M |
| Cost and Expenses | 5.0B | 5.4B | 6.8B | 5.8B | 5.8B |
| Operating Income (EBIT) | 137.4M | 189.0M | 423.7M | 240.1M | 271.7M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 138.3M | 189.9M | 422.0M | 238.9M | 278.0M |
| Income Tax Expense | 26.8M | 26.1M | 56.5M | 21.9M | 37.6M |
| Bottom Line | |||||
| Net Income | 98.1M | 144.8M | 300.3M | 196.7M | 242.2M |
| Earnings from Cont. Ops | 111.5M | 163.8M | 365.5M | 217.0M | 240.4M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 98.1M | 144.8M | 300.3M | 196.7M | 242.2M |
| Per Share | |||||
| Basic EPS | CN¥0.31 | CN¥0.46 | CN¥0.95 | CN¥0.62 | CN¥0.77 |
| Diluted EPS | CN¥0.31 | CN¥0.44 | CN¥0.86 | CN¥0.62 | CN¥0.77 |
| Revenue Per Share | CN¥16.62 | CN¥17.54 | CN¥22.68 | CN¥18.97 | CN¥19.19 |
| Shares | |||||
| Basic Shares Outstanding | 309.6M | 314.9M | 316.1M | 317.3M | 314.5M |
| Diluted Shares Outstanding | 309.6M | 314.9M | 316.1M | 317.3M | 314.5M |
| Profitability Metrics | |||||
| EBITDA | — | 270.0M | 497.7M | 303.9M | 319.9M |
| D&A | — | 80.9M | 74.0M | 63.8M | 48.3M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026